See also this year's filing and all EDGAR filings for this company.
PDF Report 0001178670_2017_ALNYLAM_PHARMACEUTICALS_INC.pdf
Logs
| error | IME and Company effects mismatched for Other Assets. IME Effects: 67.9, Company Effect: 67.8 | subcommand.report | {} |
| info | original effects; company_effects: 67.85, ime_effects: 67.9 | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001178670')"} |
Graph
Absolute values for 0001178670, ALNYLAM PHARMACEUTICALS INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 671,877,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 114,572,000 |
| 3 | remainder_Assets | 476,361,000 |
| 4 | LiabilitiesCurrent | 131,699,000 |
| 5 | LiabilitiesNoncurrent | 3,067,000 |
| 6 | remainder_Liabilities | 207,823,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 89,354,000 |
| 9 | ResearchAndDevelopmentExpense | 382,392,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 61,638,000 |
| 13 | remainder_ComprehensiveNetIncome | -37,810,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,262,810,000 |
| 1 | Liabilities | 342,589,000 |
| 2 | Expenses | 471,746,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 920,221,000 |
| 5 | NetIncome | -410,108,000 |
| 6 | ComprehensiveNetIncome | -429,013,000 |
| 7 | BaseVar | 1,088,296,500 |
| 8 | EconomicCapitalRatio | 1.44 |
Edgar->Model Mapping
Feature Distribution
